Q10 and Lenvima drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Q10 (coenzyme q - 10) and Lenvima (lenvatinib mesylate). Common drug interactions include kidney infection among females and blood pressure increased among males.

The phase IV clinical study analyzes what interactions people have when they take Q10 and Lenvima. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Q10?

Q10 has active ingredients of coenzyme q - 10. eHealthMe is studying from 34,259 Q10 users. Check the latest studies of Q10.

What is Lenvima?

Lenvima has active ingredients of lenvatinib mesylate. eHealthMe is studying from 21,113 Lenvima users. Check the latest studies of Lenvima.



On Jul, 11, 2026

46 people who take Q10 and Lenvima together, and have interactions are studied.

Q10 and Lenvima drug interactions.

What are the common drug interactions of Q10 and Lenvima, by gender? *:

female:

  1. Kidney infection
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  4. Disturbance in attention
  5. Dry mouth
  6. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  7. Abdominal pain upper
  8. Blood pressure decreased
  9. Constipation
  10. Death

male:

  1. Blood pressure increased
  2. Asthenia (weakness)
  3. Cardiac disorder
  4. Diarrhoea
  5. Fatigue (feeling of tiredness)
  6. Fluid intake reduced
  7. Heart rate increased
  8. Hypotension (abnormally low blood pressure)
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  10. Urine output decreased

What are the common drug interactions of Q10 and Lenvima, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Back pain
  3. Blood pressure increased
  4. Diarrhoea
  5. Headache (pain in head)
  6. Nausea (feeling of having an urge to vomit)
  7. Vomiting

40-49:

n/a

50-59:

  1. Pleural effusion (water on the lungs)
  2. Syncope (loss of consciousness with an inability to maintain postural tone)
  3. Tooth discolouration (a change in colour of teeth)
  4. Headache (pain in head)
  5. Dyspnoea (difficult or laboured respiration)
  6. Asthenia (weakness)
  7. Blood pressure increased
  8. Diarrhoea
  9. Dizziness
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Blood pressure increased
  2. Diarrhoea
  3. Vomiting
  4. Pruritus (severe itching of the skin)
  5. Weight decreased
  6. Urinary tract infection
  7. Dehydration (dryness resulting from the removal of water)
  8. Pain
  9. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  10. Malignant neoplasm progression (cancer tumour came back)

What are the existing conditions these people have? *

  1. Thyroid Cancer: 11 people, 23.91%
  2. Renal Cell Carcinoma (a kidney cancer): 9 people, 19.57%
  3. Endometrial Cancer: 8 people, 17.39%

* Approximation only. Some reports may have incomplete information.

Do you take Q10 and Lenvima?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Q10 and Lenvima:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Q10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lenvima:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Q10 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenvima and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 and lenvatinib mesylate (the active ingredients of Q10 and Lenvima, respectively), and Q10 and Lenvima (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: